Menu
This opportunity is currently closed.
Sign up for Content alerts to stay informed when this or related funding opportunities are posted.
RESEARCH FUNDING
SITC-AstraZeneca Immunotherapy in Lung Cancer Clinical Fellowship (worldwide)
The SITC-AstraZeneca Immunotherapy in Lung Cancer Clinical Fellowship from the Society for Immunotherapy of Cancer (SITC) with funding from AstraZeneca, supports a postdoctoral researcher, resident, research scientist, or comparable position, working on research and translation of immunotherapeutic approaches for the treatment of patients with lung cancer. Applicants must be a member of the SITC and hold an MD, PhD or MD/PhD degree. Applications are open to candidates worldwide. The fellowship provides funding of 100,000 USD over 1 year plus financial support to attend SITC´s 38th Annual Meeting.
Applications close on March 27, 2023.
Full application due:
March 27, 2023
March 27, 2023
